California State Teachers Retirement System (CalSTRS)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Buy
182,456
+3,313
+2% +$29.7K ﹤0.01% 1472
2025
Q1
$1.34M Sell
179,143
-5,342
-3% -$40.1K ﹤0.01% 1535
2024
Q4
$1.39M Buy
184,485
+7,232
+4% +$54.4K ﹤0.01% 1601
2024
Q3
$1.35M Sell
177,253
-5,615
-3% -$42.7K ﹤0.01% 1616
2024
Q2
$1.13M Sell
182,868
-1,920
-1% -$11.9K ﹤0.01% 1689
2024
Q1
$939K Sell
184,788
-15,173
-8% -$77.1K ﹤0.01% 1827
2023
Q4
$1.2M Sell
199,961
-8,815
-4% -$52.8K ﹤0.01% 1723
2023
Q3
$1.48M Sell
208,776
-20,102
-9% -$142K ﹤0.01% 1571
2023
Q2
$1.61M Sell
228,878
-3,905
-2% -$27.5K ﹤0.01% 1619
2023
Q1
$1.94M Sell
232,783
-3,067
-1% -$25.6K ﹤0.01% 1499
2022
Q4
$2.71M Buy
235,850
+2,881
+1% +$33.1K ﹤0.01% 1301
2022
Q3
$2.94M Sell
232,969
-3,916
-2% -$49.3K 0.01% 1210
2022
Q2
$2.51M Buy
236,885
+6,077
+3% +$64.3K ﹤0.01% 1347
2022
Q1
$3.75M Sell
230,808
-18,283
-7% -$297K ﹤0.01% 1216
2021
Q4
$3.45M Buy
249,091
+6,973
+3% +$96.6K ﹤0.01% 1393
2021
Q3
$3.48M Sell
242,118
-2,936
-1% -$42.2K ﹤0.01% 1372
2021
Q2
$3.87M Sell
245,054
-21,305
-8% -$337K ﹤0.01% 1347
2021
Q1
$2.71M Sell
266,359
-985
-0.4% -$10K ﹤0.01% 1557
2020
Q4
$1.99M Hold
267,344
﹤0.01% 1652
2020
Q3
$918K Buy
267,344
+33,309
+14% +$114K ﹤0.01% 1913
2020
Q2
$1.12M Buy
234,035
+5,181
+2% +$24.7K ﹤0.01% 1803
2020
Q1
$458K Buy
228,854
+2,637
+1% +$5.28K ﹤0.01% 2109
2019
Q4
$780K Buy
226,217
+54,626
+32% +$188K ﹤0.01% 2113
2019
Q3
$492K Buy
171,591
+3,302
+2% +$9.47K ﹤0.01% 2312
2019
Q2
$638K Hold
168,289
﹤0.01% 2222
2019
Q1
$1.37M Sell
168,289
-10,151
-6% -$82.6K ﹤0.01% 1757
2018
Q4
$1.44M Buy
178,440
+11,508
+7% +$92.9K ﹤0.01% 1683
2018
Q3
$1.27M Buy
166,932
+16,224
+11% +$124K ﹤0.01% 1905
2018
Q2
$864K Buy
150,708
+1,485
+1% +$8.51K ﹤0.01% 2147
2018
Q1
$712K Sell
149,223
-5,232
-3% -$25K ﹤0.01% 2162
2017
Q4
$758K Buy
154,455
+26,410
+21% +$130K ﹤0.01% 2158
2017
Q3
$671K Sell
128,045
-13,838
-10% -$72.5K ﹤0.01% 2242
2017
Q2
$789K Sell
141,883
-15,500
-10% -$86.2K ﹤0.01% 2203
2017
Q1
$1.32M Buy
157,383
+6,200
+4% +$52.1K ﹤0.01% 1894
2016
Q4
$957K Sell
151,183
-4,300
-3% -$27.2K ﹤0.01% 2135
2016
Q3
$686K Buy
155,483
+1,400
+0.9% +$6.18K ﹤0.01% 2313
2016
Q2
$438K Buy
154,083
+500
+0.3% +$1.42K ﹤0.01% 2544
2016
Q1
$435K Buy
153,583
+19,157
+14% +$54.3K ﹤0.01% 2506
2015
Q4
$1.39M Buy
134,426
+2,376
+2% +$24.5K ﹤0.01% 1802
2015
Q3
$1.51M Sell
132,050
-400
-0.3% -$4.56K ﹤0.01% 1725
2015
Q2
$1.98M Buy
132,450
+4,563
+4% +$68.1K ﹤0.01% 1662
2015
Q1
$1.16M Sell
127,887
-1,900
-1% -$17.2K ﹤0.01% 1936
2014
Q4
$1.58M Buy
129,787
+553
+0.4% +$6.72K ﹤0.01% 1746
2014
Q3
$1.26M Buy
129,234
+1,334
+1% +$13K ﹤0.01% 1842
2014
Q2
$1.63M Buy
+127,900
New +$1.63M ﹤0.01% 1744